CD4+ T cells are outnumbered by CD8+ T cells in the ratio of 1 to 10 in MS lesions and data suggest that CD8+ T cells proliferate in response to myelin antigens, subsequently trafficking to sites of inflammation. Here, CD8A is linked to myeloid sarcoma.